Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Recapitulate the Predilection of Breast Cancer Patients to Doxorubicin–Induced Cardiotoxicity

Doxorubicin (Adriamycin) is an anthracycline chemotherapy agent effective in treating a wide range of malignancies with a well–established dose–response cardiotoxic side effect that can lead to heart failure. At present, it is not possible to predict which patients will be affected by doxorubicin-in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Nat Med
Glavni autori: Burridge, Paul W., Li, Yong Fuga, Matsa, Elena, Wu, Haodi, Ong, Sang–Ging, Sharma, Arun, Holmström, Alexandra, Chang, Alex C., Coronado, Michael J., Ebert, Antje D., Knowles, Joshua W., Telli, Melinda L., Witteles, Ronald M., Blau, Helen M., Bernstein, Daniel, Altman, Russ B., Wu, Joseph C.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5086256/
https://ncbi.nlm.nih.gov/pubmed/27089514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4087
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items